Binding sites for transcription factor Sp1 have been implicated in the transcriptional regulation of several genes by hormones or vitamins, and here we show that a GC-rich element contributes to the retinoic acid response of the interleukin 1β promoter. To explain such observations, it has been proposed that nuclear receptors can interact with Sp1 bound to GC-rich DNA. However, evidence supporting this model has remained indirect. So far, nuclear receptors have not been detected in a complex with Sp1 and GC-rich DNA, and the expected ternary complexes in non-denaturing gels were not seen. In search for these missing links we found that nuclear receptors [retinoic acid receptor (RAR), thyroid hormone receptor (TR), vitamin D $ receptor, peroxisome-proliferator-activated receptor and retinoic X receptor] induce an electrophoretic mobility increase of Sp1-GCrich DNA complexes. Concomitantly, binding of Sp1 to the
INTRODUCTION
Sp1 is a ubiquitous transcription factor in mammals [1] [2] [3] . Its activity appears to be modulated by phosphorylation [4] , glycosylation [5] , levels of expression [3] , the specific sequence of the binding sites [6] and by other members of the Sp family [7] . Despite the multiple levels of regulation, Sp1 is generally considered to be a housekeeping factor of rather constitutive activity. In contrast, nuclear receptors (NRs) are principally recognized as ligand-inducible mediators of transcription in metazoans, although for the subset known as orphan receptors cognate ligands have not been identified. The classic mechanism of gene regulation by NRs involves binding of dimers to symmetrical DNA elements. Two major subfamilies of the NR superfamily can be distinguished based on their mode of interaction with DNA : members of the steroid-receptor subfamily (e.g. oestrogen receptor, ER, and progesterone receptor) form homodimers upon interaction with their ligand, and bind preferentially to palindromic sequences [8] . In contrast, members of the thyroid-receptor subfamily [thyroid hormone receptor (TR), vitamin D $ receptor (VDR), retinoic acid receptor (RAR) and peroxisome-proliferator-activated receptor (PPAR)] bind as heterodimers in complex with the retinoid X receptor (RXR) to direct repeat elements [9] [10] [11] [12] [13] . For a review of RAR see [14] . Transactivation by NRs is modulated by cofactors [15] .
Retinoids exert profound effects on immune response and wound healing [16, 17] . Interleukin 1β (IL-1β) [18] , a proinflammatory protein that is activated in response to infections and many kinds of injury, is transcriptionally up-regulated by alltrans retinoic acid (RA) [19] [20] [21] . However, no consensus sequence for RAR has been described in its promoter. To elucidate the Abbreviations used : CAT, chloramphenicol acetyltransferase ; ER, oestrogen receptor ; IL-1β, interleukin 1β ; NR, nuclear receptor ; PPAR, peroxisomeproliferator-activated receptor ; RA, all-trans retinoic acid ; RARE, RA-response element ; RAR, RA receptor ; TR, thyroid hormone receptor ; VDR, vitamin D 3 receptor ; RXR, retinoid X receptor ; GST, glutathione S-transferase ; EMSA, electrophoretic mobility-shift assay ; T 3 , 3,3h,5-tri-iodo-L-thyronine. 1 To whom correspondence should be addressed (e-mail MattHusmann!web.de).
GC-box is enhanced. It is proposed that nuclear receptors may partially replace Sp1 in homo-oligomers at the GC-box. RARs and Sp1 can also combine into a complex with a retinoic acidresponse element. The presence of RAR and Sp1 in complexes with either cognate site was revealed in supershift experiments. The C-terminus of Sp1 interacts with nuclear receptors. Both the ligand-and DNA-binding domains of the receptor are important for complex formation with Sp1 and GC-rich DNA. In spite of similar capacity to form ternary complexes, RAR but not TR up-regulated an Sp1-driven reporter in a ligand-dependent way. Thus additional factors limit the transcriptional response mediated by nuclear receptors and Sp1.
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mechanism of RA sensitivity of the IL-1β promoter we analysed the response of promoter CAT (chloramphenicol acetyltransferase) constructs in transfection experiments. These led to the conclusion that an Sp1 site confers RA sensitivity to the IL-1β promoter, and prompted us to investigate the interaction of RAR, Sp1 and GC-rich DNA. Recently it has been shown in a pull-down assay that a glutathione S-transferase (GST)-RAR fusion protein can bind Sp1 [22] . Similarly, physical interaction of Sp1 with the steroid receptors progesterone receptor [23] and ER [24] and with the orphan receptor COUP-TF (chicken ovalbumin upstream promoter transcription factor) [25, 26] had already been demonstrated. That ER and RAR might interact with Sp1 sites via protein-protein interaction was suggested by the observation that Sp1 binding to its cognate DNA in mobilityshift assays is enhanced by ER and also by the RAR fusion protein [22, 27] . However, ternary complexes were not detected when receptor was added to binding reactions with Sp1 and GCrich DNA [27, 28] and nor could supershifts of suspected NRSp1-GC-rich DNA complexes be induced with anti-receptorantibodies [22, 26] . These results call into question whether NRs can interact with Sp1 when it is bound to GC-rich DNA. The analysis of IL-1β regulation by RA led us to address this issue. Our data substantiate the hypothesis of a physical NR-Sp1-GCbox interaction, on which the emerging concept of Sp1-mediated hormone and vitamin action is based [22, 23, 26, 29] . 
MATERIALS AND METHODS

Proteins and cell extracts for electrophoretic mobility-shift assay (EMSA) and binding assays
GST-RARα and deletion constructs
RARα cDNA was amplified from pECE-RARα [13] with forward primer (5h-TAGGATCCATGGCCAGCAACAGCAGCTCC3h) and reverse primer (5h-TAGGATCCTCACGGGGAGTGG-GTGGCCGG-3h) and cloned into the BamHI site of pGEX-2tk (Amersham Pharmacia Biotech) to yield an in-frame fusion of the GST and RARα cDNAs. Deletion constructs of RARα-pGEX-2tk were made by using restriction sites in the RARα cDNA as indicated in Figure 9 (see below). Construct ∆1 was generated by digesting RARα-pGEX-2tk with KpnI and SacI and insertion of the linker pair 5h-CCGGTGCCTCCCTACG-AGCT-3h\5h-CGTAGGGAGGCACCGGGTAC-3h ; ∆2 was made by insertion of the linker pair 5h-CATTGAGAAGTGA3h\5h-TCACTTCTCAATGAGCT-3h into SmaI and SacI sites ; ∆3 originated from a digest with SmaI cleaving within the Cterminal portion of the RARα cDNA and also in the multiple cloning site of the parent vector, and re-ligation with the doublestranded linker 5h-GGGCTCCT-3h. The recombinant plasmids were verified by automated sequencing. Expression in Escherichia coli BL21 DE3, affinity purification and analysis of fusion proteins were achieved according to the protocols supplied with the GST purification and detection modules (Pharmacia).
Oligonucleotides for EMSA
All oligonucleotides given below and the complementary strands were synthesized by MWG Biotech (Ebersberg, Germany). IL-1βWT, 5h-AGCTCAGAGAATTATCTCAGTTTATTAG-TCCCCTCCCCTAAGA-3h, comprises a sequence of the proximal human wild-type IL-1β promoter that contains an Sp1-binding site (underlined) [30] . IL-1βMUT is a mutated version of IL-1βWT with three base changes (in bold) in this Sp1 site (5h-…TCCCCTAAACT…-3h). The GC-box oligonucleotide, 5h-CTTGGTGGGGGCGGGGCCTAAGCT-3h, corresponds to the core sequence of the oligonucleotide that was used for affinity purification of Sp1 (Promega) ; the GC-box is underlined. ZIP denotes a promoter region of the IL-2 gene which has been shown to bind Sp1 and other zinc-finger proteins [31] , the sequence of the ZIP oligonucleotide used in this study is 5h-TTCTTAAGGGGGTGGGGATACA-3h. The EMSA probes derived from the CD14 and the low-density-lipoprotein receptor genes, 5h-CCAGGAAAGGAAGGGGGCTGGCTCGGAGG3h and 5h-GCAGGGGGAGGAGTTTGCTAG-3h, respectively, have been described earlier [32, 33] . The Sp1-binding sites are underlined. The RA-response element (RARE) oligonucleotide with the sequence 5h-AGGGTTCACCGAAAGTTCAC-3h is derived from the proximal RARβ2 promoter. The imperfect direct repeat constituting the RARE is underlined [34, 35] .
EMSA
EMSA and the preparation of nuclear extracts were done essentially as described in [30] . Probes were generated by annealing complementary synthetic oligonucleotides and labelling with [γ-$#P]ATP (NEN Life Science Products) using polynucleotide kinase (Roche, Mannheim, Germany). Free [γ-$#P]ATP was removed by non-denaturing PAGE or by two rounds of spin-column chromatography with Chromaspin TM columns (ClonTech). EMSA binding reactions contained 10 mM Hepes, pH 7.9, 50 mM KCl, 1 mM dithiothreitol, 2.5 mM MgCl # , 10 % glycerol and 2 µg of poly(dI-dC) in a total volume of 30 µl. After preincubating the various recombinant proteins or cell extracts (see Figure legends 
GST pull-down assay
GST or GST-Sp1 fusion proteins were bound to Sepharose 4B beads (Amersham Pharmacia Biotech). Subsequently, the beads were incubated with purified VDR (100 ng) for 1 h at room temperature, washed five times with NETN buffer (20 mM Tris\HCl, pH 8\50 mM NaCl\1 mM EDTA\0.5 % Nonidet P-40), dried, boiled in loading buffer for 5 min and loaded on to SDS\PAGE (10 % gel). After electrophoretic separation proteins were blotted on to Hybond-P-membranes (Amersham Pharmacia Biotech). VDR was detected by using an affinity-purified polyclonal antibody (Santa Cruz Biotechnology) and the alkaline phosphatase-based Protoblot detection kit from Promega.
Plasmids for transfection experiments
The construction of hybrid plasmids comprising human IL-1β promoter segments (k777\j108, k674\j108, k513\j108, 234\j108, k209\j108 and k131\j108) in pBLCAT $ and the internal deletion construct IL-1β(k777\k234Dk131\ j108)CAT have been described previously [30] . Plasmid IL-1β(k209\j108)MUT-CAT contained a mutation of the wildtype sequence 5h-TCCCCTCCCCT-3h to 5h-TCCCCTAAACT-3h and was made by PCR-mediated mutagenesis. The reporter construct TRE # -tk-CAT contained two copies of a perfect palindromic sequence and has been shown to respond to receptors for RA or T $ (3,3h,5-tri-iodo--thyronine) [36] . The construction of pECE-RAR and pECE-TR expression vectors has been described previously [13, 36] . The sequences of all constructs were verified by dye-terminator cycle sequencing using an ABI 373 automatic sequencer. pPacSp1 for the expression of Sp1 in Drosophila cells was a generous gift of Dr R. Tjian (University of California at Berkeley, CA, U.S.A.) [37] . Plasmid preparations for transfections were obtained by two rounds of CsCl density-gradient centrifugation. Ternary complexes of nuclear receptors, Sp1 and GC-rich DNA
Cell lines, culture conditions, transient transfections and CAT assays
CV-1 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, U.S.A.), Schneider cells (S2) were from Deutsche Sammlung fu$ r Mikroorganismen und Zellkulturen (Braunschweig, Germany) and HaCaT cells [38] were a gift from Dr N. Fusenig (Deutsches Krebsforschungszentrum, Heidelberg, Germany).
Plasticware for cell cultures was from Nunc (Wiesbaden, Germany) and cell-culture media and fetal bovine serum were from Biochrom (Berlin, Germany). CV-1 cells and HaCaT cells were kept in Dulbecco's modified Eagle's medium containing 10 % heat-inactivated (56 mC, 30 min) fetal bovine serum in a humidified incubator with 5 % CO # . S2 cells were cultured at 25 mC in Schneider's Drosophila medium supplemented with 10 % fetal bovine serum (both from Life Technologies). The transfection procedure using calcium phosphate precipitation was essentially as described previously [35] . CV-1 cells were seeded at a density of $ 1.5i10'\100 mm dish 16-24 h before transfection. Transfection mixtures contained 3 µg of pCH110 (Amersham Pharmacia Biotech) for β-galactosidase expression to correct for variations of transfection efficiency, 6 µg of reporter plasmid and between 0.1 and 4.0 µg of receptor-expression plasmids (see the Figure legends) ; pBluescript (Stratagene) was added to give a total of 20 µg of plasmid DNA. Plasmids were diluted in a total volume of 460 µl of water. Subsequently, 40 µl of a 2.5 M stock solution of CaCl # were added. This mixture was combined with 500 ml of a 2iHepes buffer (280 mM NaCl\ 10 mM KCl\1.5 mM Na # HPO % ,2H # O\12 mM dextrose\50 mM Hepes), and added to the cultures. Cells were incubated for 16 h with the transfection mixtures. Removal of the media containing the transfection mixtures was followed by a brief rinse with 5 ml of PBS, and fresh media containing charcoal-stripped fetal bovine serum and ligand, or media with solvent alone, were added. Cells were lysed by three cycles of freezing in liquid nitrogen and thawing. Lysates were cleared by centrifugation at 10 000 g for 5 min.
Figure 1 An Sp1-binding site contributes to the RA response of the IL-1β promoter
IL-1β-CAT reporter constructs comprising varying segments of the IL-1β promoter were generated. The positions of restriction-enzyme-recognition sites and the Sp1 site are indicated ; the mutated site is crossed out. CV-1 cells were co-transfected by calcium phosphate precipitation (see the Materials and methods section for details) with 6 µg of the respective reporter construct, and expression vectors for RAR (1 µg) and β-galactosidase (3 µg). The data represent the ratios of β-galactosidase-corrected CAT activities from parallel cultures treated with RA (1 µM) or solvent only. Deletion or mutation of the Sp1 site reduces induction by RA. The number of independent experiments (n) is indicated ; S.E.M. are given for data sets with n 4.
The activity of CAT in lysates was determined using a liquid scintillation\extraction procedure employing [$H]acetyl-CoA (NEN Life Science Products) as a substrate [39] . The activity of β-galactosidase in the lysates was assessed with o-nitrophenyl β--galactopyranoside (Sigma) as a substrate, as described previously [40, 41] . Transfection of S2 Drosophila cells was performed using a calcium phosphate precipitation procedure [42] , and CAT activities were determined 72 h after transfection with equal amounts of protein from whole-cell lysates. Protein was measured using Bradford reagent (Bio-Rad, Richmond, CA, U.S.A.).
RESULTS
An Sp1 site renders the IL-1β promoter sensitive to RA
IL-1β is transcriptionally up-regulated by RA [19] [20] [21] . However, a classic RARE has not been described in its gene. To identify promoter regions that may be involved in RA-mediated transcriptional regulation we transiently co-transfected CV-1 cells with IL-1β-promoter-CAT constructs and RARα. As shown in Figure 1 , full induction by RA was dependent on a promoter segment between positions k234 and k131. Because Sp1 sites have been implicated in vitamin or hormone action we suspected that an atypical Sp1 site, which we had identified previously in this promoter region [30] , might be involved in the regulation of the IL-1β promoter by RA. This idea was then supported by the finding that a mutation of the Sp1 site virtually abolished the response to RA.
The RA response of the IL-1β promoter is ligand-specific and depends on RAR Dose-response curves for RA and retinol revealed the ligandspecificity of IL-1β activation by RA (Figure 2A) . A slight inhibition of basal levels was observed in retinol-treated cultures. Retinol might compete with minute amounts of RA present in the culture system, and act as an inhibitory ligand of regulatory proteins. While RARα induced the reporter in the presence of RA, TRα was not capable of activating IL-1β(k234\j108)CAT in the presence or absence of its cognate ligand. A reporter containing two copies of a perfect palindromic sequence was employed as a control for functional expression and ligand activation of RAR and TR. The promiscuous response element was activated strongly by either combination of receptor and cognate ligand ( Figure 2B ). Thus differential activation of the IL-1β promoter by RAR and TR was not due to differential expression of functional receptors. RA-dependent activation of IL-1β(k209\j108)CAT increased with the amount of transfected RAR cDNA in a range between 0.1 and 2.0 µg. Of the RAR subtypes, RARα proved to be the most efficient ($ 4-5-fold increase with 1 µM RA), whereas RARβ yielded 2-3-fold activation and RARγ virtually no induction with RA (results not shown). This resembled the receptor-typic activation pattern observed previously with some classic RAREs [43, 44] .
Sp1 and ponasterone activate the IL-1β promoter in Drosophila cells
Sp1 sites may bind a variety of regulatory proteins. Before embarking on studies of molecular interactions, we therefore wished to establish that Sp1 can functionally interact with the IL-1β promoter. For this purpose we performed transfection experiments with insect cells, which do not naturally express Sp1. Co-transfection of Sp1 expression vector increased the activity of the IL-1β-promoter reporter 5-fold (P 0.02 for Sp1 versus empty expression-vector control ; Figure 2C ). When ponasterone, a ligand for the nuclear ecdysone receptor of insect cells, was added to these cultures an additional 5-fold activation was observed, while a 2-fold induction was seen in control cells without Sp1. Although this difference did not reach statistical significance (P 0.1 for Sp1-versus control-transfected cells), it may reflect a functional interaction of ecdysone receptor with Sp1.
GST-RAR, Sp1 and the GC-box form a ternary complex
To study potential interactions of Sp1, RAR and the Sp1-binding site of the IL-1β promoter we labelled an oligonucleotide probe comprising this element and employed it in EMSAs with bacterially expressed RAR fusion protein and purified Sp1. As expected, Sp1 retarded the labelled probe and GST-RARα did not. However, addition of GST-RARα to Sp1 increased both the mobility and intensity of Sp1 bands (Figure 3, top-left panel) . GST exerted no effect. RA did not influence complex formation in the absence or presence of receptor. Complexes did not form when oligonucleotides containing mutations in the Sp1 site were used. A number of TC-rich sites from other promoters gave results similar to the IL-1β Sp1-site oligonucleotide (Figure 3 , bottom-left panel), and we reasoned that enhancement of Sp1 binding by receptor may be limited to a sub-population of Sp1 sites, possibly to sites of low affinity for Sp1 [6] . However, the enhancing effect of GST-RARα was also evident when a consensus GC-box oligonucleotide was used as a probe (Figure 3 
TR, VDR, PPAR and RXR, but not several unrelated proteins, enhance binding of Sp1 to the GC-box
We wished to know whether other members of the thyroidreceptor subfamily could also serve as auxiliary factors for Sp1. 
Figure 4 Comparison of the effect of GST-TR, native VDR and other proteins on Sp1 binding
Figure 5 Stability of VDR-Sp1-GC-box and Sp1-GC-box complexes
Binding reactions with GC-box probe and 20 ng of Sp1 (left-hand half of the gel), or 2 ng of Sp1 plus 10 ng of VDR (right-hand half ) were performed in the presence of a 200-fold excess of unlabelled probe oligonucleotide and incubated for the indicated times (t comp ; h, min ; hh, s) before electrophoretic separation of complexes and free probe. In fact, GST-TRα enhanced Sp1 binding to the GC-box ( Figure  4 ). Virtually identical results were also obtained with GST-PPARγ and GST-RXRα (results not shown). In order to investigate the effect of a native class-II receptor on Sp1 binding to GC-rich DNA, we extended our study to a VDR preparation from a baculovirus expression system. Like the fusion proteins of RAR, TR, RXR and PPAR, native VDR produced marked complex formation with Sp1 at concentrations where neither protein alone generated visible bands. In contrast, a panel of various proteins unrelated to NR did not cause enhanced Sp1 binding. This ruled out the possibility of an unspecific effect being responsible for the increased band intensity.
VDR stabilizes binding of Sp1 to its target site
Competition experiments with unlabelled oligonucleotides were performed to compare the stability of Sp1-GC-rich DNA and Sp1-VDR-GC-rich DNA complexes. These experiments revealed that the ternary complexes are far more stable. While Sp1 complexes disassembled after brief exposure (30 s) to a 200-fold excess of unlabelled oligonucleotide, ternary Sp1-VDR complexes remained stable for at least 16 min under these conditions ( Figure 5 ).
Comparison of Sp1 complexes from cell extracts and purified Sp1
If Sp1 associates with NRs or other proteins in the cellular milieu, this would be expected to result in an increased mobility of Sp1 complexes from cellular extracts as compared with complexes from purified Sp1. In fact, Sp1 bands obtained with
Figure 7 Antibody-induced mobility shift of RAR-Sp1-GC-box complexes
EMSA with the GC-box probe was performed with mixtures of RAR fusion protein and Sp1 in various ratios (the numbers given shown represent pre-diluted protein preparations in µl : 1 and 4 correspond to 25 and 100 ng of GST-RARγ 1 , and 3 and 6 to 5 and 10 ng of Sp1). Antibodies (2 µg per lane) were added to the protein mixtures 2 h prior to the addition of probe. α-Sp1 and RARα both induced a mobility shift of the complexes while α-CEBP (CCAAT-enhancerbinding protein) had no effect.
Figure 8 Sp1-RAR interaction on a RARE
EMSA was performed with a RARE as the probe. Binding reactions contained 25 ng of Sp1 and/or 500 ng of GST-RARα, and antibodies (Ab) as indicated. 4, RAR-RARE complex ; arrowheads mark supershifted bands ; , undefined complex ; $, free probe.
mammalian cell extracts migrated faster than Sp1 complexes obtained with the purified protein ( Figure 6 ). As expected, insectcell extracts did not yield the typical Sp1 band. However, when combined with low amounts of Sp1 that were insufficient to give an appreciable signal in the absence of helper factors, insect-cell extracts supported the formation of a strong Sp1 complex. Notably, Sp1 complexes from extracts migrate like those of purified Sp1 plus receptor. Thus cell extracts contain helper factors, which potently enhance and modulate Sp1 interaction with the GC-box.
Detection of RAR and Sp1 in a complex with the GC-box by antibody-mediated mobility shift
To demonstrate the presence of Sp1 and receptor in the presumptive ternary complexes, EMSAs with specific antibodies were performed. While anti-Sp1 readily induced a supershift, initial experiments using antibodies against peptide sequences of the C-terminus of RARα or anti-GST antibodies failed (results not shown). In contrast, when we performed an experiment with RARγ1 and an affinity-purified antibody raised against the whole molecule a shift of the ternary complex was elicited ; no shift was observed with anti-CEBP (CCAAT-enhancer-binding protein ; see Figure 7 ). Additional negative controls not shown in Figure 7 included a series of other irrelevant antibodies, and binding reactions where larger amounts of Sp1 were used and RAR was omitted.
Sp1 and RAR can interact on a RARE
Up to this point, all EMSAs had been performed with Sp1-binding sites. We wished to know whether complexes can also form with RAR, Sp1 and consensus sites for the receptor. Accordingly we employed a response element for RAR as a probe. As expected, no binding of Sp1 alone was seen. In contrast, GST-RAR yielded a retarded complex, and the intensity of the band was enhanced when Sp1 was added to the binding reaction. Antibody against Sp1 completely abolished this signal and antibody to RARα yielded two species of supershifted bands. From these data we conclude that in principle Sp1 can interact with RAR bound to a RARE (Figure 8 ).
RAR domains in the N-and C-terminal halves contribute to ternary complex formation with Sp1 and GC-rich DNA
In order to delineate receptor domains required for ternary complex formation with Sp1 and GC-rich DNA we constructed GST-RARα fusion proteins containing partial deletions of the receptor, and employed them in EMSAs (Figure 9) . A deletion of the extreme C-terminal end had only a minimal effect, and removal of the ligand binding domain almost abolished ternary complex formation. A construct with a deletion of the DNAbinding domain had a reduced capacity to enhance Sp1 binding.
The C-terminus of Sp1 interacts with VDR
To determine domains of Sp1 that interact with NRs we performed pull-down assays with VDR and GST fusion proteins containing Sp1 or parts of the molecule. Immobilized GST fusion proteins comprising either the C-terminus of Sp1 (622-788) or the whole Sp1 molecule bound VDR (Figure 10) . Upon extended development, binding to the Sp1(1-622) fusion protein was also evident (results not shown). In contrast, VDR did not interact with the N-terminus of Sp1 (1-293).
DISCUSSION
The primary finding of this work is that NRs can form ternary complexes with Sp1 and GC-rich DNA. Recently, this interaction has been postulated to explain Sp1-site-dependent hormone or vitamin responses of several target genes in the absence of classic response elements. Our data suggest that such a mechanism may also be involved in the activation of the IL-1β promoter by RA. The identification of NR-Sp1-GC-box complexes was accomplished by showing that the mobility of Sp1-GC-box complexes changes in the presence of NRs, and by inducing a shift of the ensuing complexes with antibody to receptor (RAR) and also with antibody to Sp1. Unexpectedly, NR, Sp1 and the GC-box assembled into complexes of increased electrophoretic mobility compared with Sp1-GC-box complexes. This phenomenon could be due to an increased relative charge of the ternary complex [45] . Alternatively, RAR-Sp1-GC-box complexes might be of lower molecular mass than Sp1-GC-box complexes. This is possible because purified Sp1 binds as a homo-oligomer (principally as a tetramer) to the GC-box [46] . Partial replacement of Sp1 in tetramers by the smaller NR molecules would yield ternary complexes of lower mass (Figure 11 ). When Sp1 bound to RAR\RARE, it did not cause a lower mobility of the ensuing complex. Therefore, if charge shift is the cause of the mobility increase after addition of RAR to Sp1-GC-box complexes, it must result specifically from this interaction. Titration of receptor revealed at least two forms of ternary complex, and the receptorinduced mobility increase of Sp1 complexes was accompanied by a dose-dependent enhancement of band intensity. Recently,
Figure 11 Hypothetical model of ternary complex formation between Sp1, GC-rich DNA and NRs
NRs can form ternary complexes with Sp1 and the GC-box. Sp1 molecules may be displaced from homo-oligomers by receptor and might become available for binding to additional GC sites. Size and stoichiometry of NR-Sp1-GC-rich DNA complexes may be variable. enhancement of Sp1 complexes by ER [24, 27, 47] or by GST-RAR [22] has been reported ; however, no concomitant mobility increase has been observed in these studies. The reason for the discrepancy with our results is unclear. Possibly, the differential mobility of NR-Sp1 compared with Sp1 complexes depends on the degree of Sp1 glycosylation and on the NRs studied. Differences between Sp1 preparations might play a role. The mobility change represents valuable information because it indicates a change of the composition, and not only of the quantity, of the ensuing complex.
What is the mechanism of enhanced Sp1 binding in the presence of receptor ? First, conformational changes may increase the stability of Sp1-GC-rich DNA interaction. The experiment shown in Figure 5 documents that ternary complexes are in fact more stable than binary Sp1-GC-box complexes. A second mechanism could be the displacement of Sp1 molecules from homo-oligomers because it could make more Sp1 molecules available for binding to oligonucleotide.
The selectivity of Sp1-NR interactions was demonstrated with a panel of proteins unrelated to transcription factors ; they had no effect on Sp1 binding in EMSA. The differential binding of receptor to N-terminal and C-terminal domains of Sp1 underscore the specificity of the interaction. That the Sp1 C-terminus serves as an interaction domain for VDR parallels recently published data with ER and with transcription factor E2F (adenovirus E2 promoter-binding factor) [29, 48] . The ligandbinding domain of NR turned out to be most critical for the interaction with Sp1-GC-box complexes, but deletion of the DNA-binding domain significantly diminished ternary complex formation as well. This suggests that relatively large portions of the receptor may be important for binding to Sp1 and the GCbox, and could explain the failure to induce supershifts with antipeptide antibodies, while an antibody raised against the whole RAR molecule shifted the ternary complex.
All receptors tested here enhanced Sp1 binding to DNA, which implies that they may compete for Sp1. The large number of potential interaction partners of Sp1 and the stability of receptor-Sp1 complexes also raise the question of whether binding of Sp1 to GC-rich DNA regularly involves auxiliary factors. Cross-talk between Sp1 and NRs is suggested by the recent finding that both utilize a protein that is part of a coactivator complex required for transcriptional activation by Sp1 [49] . It is tempting to speculate that NR can serve to bridge this protein to other components of the co-activator complex. Functional synergy between Sp1 and VDR or RARγ may also be reflected by their genomic organization in a synteny group on chromosome 12q in humans and on chromosome 7 of the rat [50] .
Despite the common theme of Sp1-RAR interaction in the present study and the previous work of Suzuki et al. [22] , different mechanisms may be involved in these two cases. Thus in contrast to the IL-1β-CAT constructs used here, the urokinasereporter hybrids in the work of Suzuki et al. [22] did not respond to ligand. Possibly, various pathways can lead to ligand-induced transcription via Sp1-NR. These may include post-translational modifications, enhanced Sp1 binding as a consequence of receptor upregulation and recruitment of cofactors. Which pathway prevails may depend on the specific tissue and other conditions. The different results obtained with the urokinase and the IL-1β promoter may be due to differential tissue expression of cofactors, since different cell types were used in these studies. A requirement for restricted cofactors may also explain the finding that TRα failed to induce the IL-1β reporter in CV-1 cells, although it enhanced binding of Sp1 to the GC-box in EMSA. This is in line with the recent finding with ER subtypes α and β. ERα activates transcription via Sp1 sites in a tissue-and ligand-dependent fashion while ERβ is inactive, although both ER subtypes can interact with Sp1 [29] .
To summarize, the analysis of an atypical RARE led to the identification of a ternary complex composed of NR, Sp1 and GC-rich DNA. The observations can be accommodated in a model according to which NR would partially replace Sp1 in homo-oligomers. It appears that many, if not all, NRs may bind to Sp1 ; consequently it will be important to analyse the constraints that control Sp1-dependent activation by a given NR.
